Release Date: 29/01/15 12:59 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 1.61MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%